Agios Pharmaceuticals Inc (AGIO)
EBITDA
-$109.20M
Quarterly · Period ending: · USD
AGIO EBITDA
Latest reported-$109.20Mperiod ending
Latest reported-$109.20Mperiod ending
AGIO Quarterly EBITDA (-$5.00M → -$109.20M)
Quarterly EBITDA
High-resolution chart · PNG
AGIO ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -109,202,000 | |
| -97,748,000 | |
| -107,789,000 | |
| -102,059,000 | |
| -110,761,000 | |
| -88,011,000 | |
| -104,032,000 | |
| 1,002,380,000 | |
| -94,525,000 | |
| -80,201,000 | |
| -94,537,000 | |
| -89,701,000 | |
| -81,999,000 | |
| -79,228,000 | |
| 38,340,000 | |
| -79,766,000 | |
| -89,515,000 | |
| -92,296,000 | |
| -96,382,000 | |
| -82,050,000 | |
| -80,348,000 | |
| -88,398,000 | |
| -88,966,000 | |
| -86,897,000 | |
| -86,014,000 | |
| -37,782,000 | |
| -103,966,000 | |
| -104,091,000 | |
| -107,834,000 | |
| -95,478,000 | |
| -94,445,000 | |
| -97,365,000 | |
| -71,210,000 | |
| -92,287,000 | |
| -88,476,000 | |
| -77,403,000 | |
| -83,027,000 | |
| -65,456,000 | |
| -55,687,000 | |
| -62,076,000 | |
| -55,166,000 | |
| -22,348,000 | |
| -39,753,000 | |
| -39,428,000 | |
| -31,353,000 | |
| -4,825,000 | |
| -26,365,000 | |
| 3,554,000 | |
| -18,003,000 | |
| -11,952,000 | |
| -11,902,000 | |
| -10,692,000 | |
| -8,152,000 | |
| -6,697,000 | |
| -6,174,000 | |
| -4,791,000 | |
| -5,850,000 | |
| -5,000,000 |